I have approached applying to participate in this clinical Trial. It is to determine the efficacy of using Ropeginterferon alfa-2b-njft for the treatment of Essential Thrombocythemia. It has been approved for use in the treatment of PV, but not ET in the US, as I understand it.
When I read the study details it says that the injection will be every 2 weeks, and have a starting dose of 250 mcg, then 350 mcg week 2, working up to a dose of 500 mcg at week 4 for a 12 month treatment period. It goes on to say if you were on HU or anagrelide you will follow a pre-specified dose-tapering schedule. Not sure if that means your dose of HU, Anagrelide, or the Interferon.
My question is for people already taking this drug.
What is your dosage and frequency of use?
How has the amount taken affected you?
What are your side effects?
How long have you been on this drug?
Do you have PV, ET, or other?
What country do you live in?
I'm desperate to get off Hydroxyurea, but don't want to have worse side effects, or switch to another chemo drug.